PIWORLD audio investor podcasts
Business:Investing
01:12 Paul’s view on Covid-19 and where we’re headed from here.
04:17 What’s actions has Paul taken with his funds to plan for today’s threats
06:35 Dunelm (DNLM)
07:15 Has CV19 increased the attraction of Biotech and Meditech? What companies in the sector is Paul most excited about?
09:54 Polarean Imaging (POLX)
13:12 Renalytix (RENX)
15:43 Current valuations
18:17 Do you feel any companies in the funds are a likely potential bid candidate?
20:33 Grainger (GRI)
21:55 Inflation, monetarism (Professor Tim Congdon: https://mv-pt.org/) and QE.
29:10 Why did Amati launch the Strategic Metals Fund?
35:24 What company are you most excited by? Saietta (SED)
44:19 What draws you to IPOs? And which do you particularly like?
45:33 Victorian Plumbing (VIC)
48:39 AlphaWave Ip (AWE)
Find out more about Paul Jourdan and the Amarti Global Investors funds: https://amatiglobal.com/
About Paul Jourdan:
Dr Paul Jourdan co-founded Amati Global Investors following the management buyout of Noble Fund Managers from Noble Group in January 2010, having joined Noble in 2007 as Head of Equities. His fund management career began in 1998 with Stewart Ivory, where he gained experience in UK, emerging market, and global equities. In 2000, Stewart Ivory was taken over by First State and Paul became manager of what is now TB Amati UK Smaller Companies Fund. In 2004, he was appointed Head of UK Equities at First State. In early 2005, he launched Amati VCT plc and he also manages Amati VCT 2 after the investment management contract moved to Amati Global Investors in 2010 (In 2018 Amati VCT merged into Amati VCT 2 which was then renamed Amati AIM VCT). Prior to 1998, Paul worked as a professional violinist, including a four-year period with the City of Birmingham Symphony Orchestra. He currently serves as a trustee of Clean Trade, a charity registered in England and Wales.
Create your
podcast in
minutes
It is Free